Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

Mol Cell Biol. 1997 Jul;17(7):4015-23. doi: 10.1128/MCB.17.7.4015.

Abstract

Tumor necrosis factor alpha (TNF-alpha) is a macrophage/monocyte-derived polypeptide which modulates the expression of various genes in vascular endothelial cells and induces angiogenesis. However, the underlying mechanism by which TNF-alpha mediates angiogenesis is not completely understood. In this study, we assessed whether TNF-alpha-induced angiogenesis is mediated through TNF-alpha itself or indirectly through other TNF-alpha-induced angiogenesis-promoting factors. Cellular mRNA levels of interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and their receptors were increased after the treatment of human microvascular endothelial cells with TNF-alpha (100 U/ml). TNF-alpha-dependent tubular morphogenesis in vascular endothelial cells was inhibited by the administration of anti-IL-8, anti-VEGF, and anti-bFGF antibodies, and coadministration of all three antibodies almost completely abrogated tubular formation. Moreover, treatment with Sp1, NF-kappaB, and c-Jun antisense oligonucleotides inhibited TNF-alpha-dependent tubular morphogenesis by microvascular endothelial cells. Administration of a NF-kappaB antisense oligonucleotide almost completely inhibited TNF-alpha-dependent IL-8 production and partially abrogated TNF-alpha-dependent VEGF production, and an Sp1 antisense sequence partially inhibited TNF-alpha-dependent production of VEGF. A c-Jun antisense oligonucleotide significantly inhibited TNF-alpha-dependent bFGF production but did not affect the production of IL-8 and VEGF. Administration of an anti-IL-8 or anti-VEGF antibody also blocked TNF-alpha-induced neovascularization in the rabbit cornea in vivo. Thus, angiogenesis by TNF-alpha appears to be modulated through various angiogenic factors, both in vitro and in vivo, and this pathway is controlled through paracrine and/or autocrine mechanisms.

MeSH terms

  • Animals
  • Cells, Cultured
  • Cornea / blood supply
  • Endothelial Growth Factors / physiology*
  • Endothelium, Vascular / physiology*
  • Fibroblast Growth Factor 2 / physiology*
  • Gene Expression Regulation, Developmental
  • Humans
  • Immunologic Techniques
  • Interleukin-8 / physiology*
  • Lymphokines / physiology*
  • Morphogenesis / drug effects
  • NF-kappa B / physiology
  • Neovascularization, Physiologic*
  • Oligonucleotides, Antisense / pharmacology
  • Proto-Oncogene Proteins c-jun / physiology
  • Rabbits
  • Sp1 Transcription Factor / physiology
  • Transforming Growth Factor alpha / physiology
  • Tumor Necrosis Factor-alpha / physiology*
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Interleukin-8
  • Lymphokines
  • NF-kappa B
  • Oligonucleotides, Antisense
  • Proto-Oncogene Proteins c-jun
  • Sp1 Transcription Factor
  • Transforming Growth Factor alpha
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factor 2